An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis

Horton, John; Tobias Witt, Christoffer; A. Ottesen, Eric; Lazdins, Janis; G. Addiss, David; Awadzi, K.; J. Beach, Michael; Y. Belizario, Vicente; Dunyo, Samuel; Espinel, Mauricio; O. Gyapong, John; Anwar Hossain, M.; M. Ismail, M.; L. Jayakody, R.; J. Lammie, Patrick; Makunde, W.H.; Richard-Lenoble, D; Selve, Billy; K. Shenoy, R.; E. Simonsen, Paul; N. Wamae, C.; V. Weerasooriya, M.

doi:10.1017/s0031182000007423

Public

An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis

Published in Parasitology • Oct 1, 2000

Authors:

John Horton

Christoffer Tobias Witt

Eric A. Ottesen

Abstract

This review of the safety of the co-administration regimens to be used in programmes to eliminate lymphatic filariasis (albendazole + ivermectin or albendazole + diethylcarbamazine [DEC]) is based on 17 studies conducted in Sri Lanka, India, Haiti, Ghana, Tanzania, Kenya, Ecuador, the Philippines, G...

Subject

Albendazole

Lymphatic filariasis

Ivermectin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!